Then we identified miR-100 as a crucial player to maintain M2 phenotype of TAMs both in vitro and in vivo by targeting mTOR pathway and upregulating the secretion of IL-1ra that could enhance tumor cell stemness. Here, MTOR is linked to neoplasm.